Abstract:Schizophrenia is a complex and disabling psychiatric disorder, and tardive dyskinesia (TD) is a severe adverse drug effect occurring in 20% to 40% of schizophrenic patients chronically treated with typical neuroleptics. Previous studies suggested that the manganese superoxide dismutase (MnSOD) activity was associated with the development of schizophrenia. Ala-9Val polymorphism, a functional polymorphism of MnSOD gene, has been reported to be related to the risk of schizophrenia and TD. However, these studies did not lead to consistent results. We performed meta-analyses aiming to assess the association between MnSOD activity and schizophrenia, as well as the association of MnSOD Ala-9Val polymorphism with schizophrenia and TD in schizophrenic patients.We search for the literature on MnSOD and schizophrenia in English or Chinese published up to May 1, 2015 on PubMed, EMBASE, the Cochrane Databases, Chinese National Knowledge Infrastructure, China Biology Medical and Wanfang databases. Two investigators independently reviewed retrieved literature and evaluated eligibility. Discrepancy was resolved by consensus with a third reviewer. Data were pooled using fixed-effect or random-effect models. The standardized mean difference (SMD) and 95% confidence interval (CI) were calculated for the MnSOD activity. Pooled odds ratio (OR) and 95% CI were calculated for Ala-9Val genotype and allele frequencies.There were 6, 6, and 10 studies entering 3 parts of meta-analyses, respectively. The MnSOD activity of patients was significantly lower than that of controls (SMD = -0.94; 95% CI: -1.76, -0.12; P = 0.025). No significant associations of Ala-9Val genotypes (OR = 1.14; 95% CI: 0.97, 1.33; P = 0.109) and alleles (OR = 1.06; 95% CI: 0.94, 1.20; P = 0.361) with the risk of schizophrenia were observed. We also did not reveal significant associations of the genotypes (OR = 0.82; 95% CI: 0.66, 1.02; P = 0.075) and alleles (OR = 0.90; 95% CI: 0.76, 1.06; P = 0.215) with the risk of TD in schizophrenia.The decreased MnSOD activity may be associated with the risk of chronic schizophrenia in Chinese population, while MnSOD Ala-9Val polymorphism may not play a significant role in the development of schizophrenia and TD. Longitudinal studies with larger sample sizes and different ethnicities are needed to confirm the association of the MnSOD Ala-9Val variants with schizophrenia and TD.

The interaction between polymorphisms in MnSOD and prostate cancer risk : a meta-analysis and systematic review

Association Between Manganese Superoxide Dismutase Gene Polymorphism and Risk of Prostate Cancer: A Meta-analysis

Association Betweenmnsodval16ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls

Association Between MnSOD Val16Ala Polymorphism and Cancer Risk: Evidence from 33,098 Cases and 37,831 Controls.

MnSOD Val16Ala Polymorphism and Prostate Cancer Susceptibility: a Meta-Analysis Involving 8,962 Subjects.

Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects

[Association of XPC gene polymorphisms with breast cancer risk].

GSTP1 Ala114Val Polymorphism and Colorectal Cancer Risk: a Meta-Analysis

MnSOD Val16Ala Polymorphism Associated with Retinopathy Risk in Diabetes: a PRISMA-compliant Meta-analysis of Case-Control Studies.

The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: A meta-analysis

The Association Between Polymorphism of Manganese Superoxide Dismutase and Oral Cancer in A Taiwan Population

Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study

Association between MutL homolog 1 polymorphisms and the risk of colorectal cancer: a meta-analysis

There is No Relationship Between SOD2 Val-16Ala Polymorphism and Breast Cancer Risk or Survival.

Single-nucleotide Polymorphisms of GPX1 and MnSOD and Susceptibility to Bladder Cancer: a Systematic Review and Meta-Analysis

A Meta-Analysis of Influence of MSMB Promoter Rs10993994 Polymorphisms on Prostate Cancer Risk

Lack of Association Between COMT Val158Met Polymorphism and Prostate Cancer Susceptibility

The association between polymorphisms in prooxidant or antioxidant enzymes (myeloperoxidase, SOD2, and CAT) and genes and prostate cancer risk in the Chinese population of Han nationality.

Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia.

Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer